SCHEMBL573875

SCHEMBL573875

CCCCN(CCCC)c1cc(C(=O)O)cc(S(N)(=O)=O)c1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 5/20 0.46
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 2/20 0.46
USP2 O75604 1/20 0.46
LMNA P02545 1/20 0.46
TSHR P16473 1/20 0.46
BLM P54132 1/20 0.46
SLC12A2 P55011 1/20 0.46
HIF1A Q16665 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HSD17B10 Q99714 1/20 0.46
ALOX5 P09917 3/20 0.43
PTGES O14684 2/20 0.39
GAA P10253 2/20 0.39
POLB P06746 2/20 0.39
CNR2 P34972 1/20 0.39
PKM P14618 1/20 0.38
CA12 O43570 3/20 0.36
CA1 P00915 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14886010 0.89 ALOX5 (0.44) CA2KDM4EALDH1A1HPGDUSP2
SCHEMBL14879711 0.89 ALOX5 (0.44) CA2KDM4EALDH1A1HPGDUSP2
SCHEMBL16581177 0.84 ALDH1A1 (0.40) CA2KDM4EALDH1A1HPGDUSP2
SCHEMBL2741938 0.83 CA2 (0.42) CA2KDM4EALDH1A1HPGDUSP2
SCHEMBL14885916 0.82 HCAR3 (0.41) CA2ALDH1A1LMNAALOX5PTGES
SCHEMBL10224398 0.82 KMT2A (0.43) KDM4EALDH1A1HPGDUSP2LMNA
SCHEMBL574554 0.82 CISD1 (0.43) CA2KDM4EALDH1A1HPGDUSP2
SCHEMBL2741926 0.82 CA2 (0.42) CA2KDM4EALDH1A1HPGDUSP2
SCHEMBL2741940 0.81 CA2 (0.46) CA2KDM4EALDH1A1HPGDUSP2
SCHEMBL229433 0.81 LMNA (0.64) CA2KDM4EALDH1A1HPGDUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598478-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2013-06-05 EP disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 WO disclosed